Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Non Small Cell Lung Cancer

Early results show erlotinib extends life for women with advanced lung cancer

Three times as many women with advanced lung cancer were alive and had no progression of their cancer 12 months after taking the drug erlotinib (also known as Tarceva)...

Existing drugs could treat smokers' lung cancer

A common cancer drug and a drug used for a rare condition affecting the heart could together treat an aggressive form of lung cancer called non-small cell lung cancer (...

Trials of AS1404 for lung cancer show encouraging results

Final data from a phase II trial of a new non-small cell lung cancer drug known as AS1404 have shown a substantial survival benefit, according to Antisoma, the company...

Skin rash predicts survival benefit from latest lung cancer drug

Elderly patients with advanced non small cell lung cancer (NSCLC) who developed a rash within 28 days of receiving the targeted drug erlotinib (Tarceva) survived on...

NICE recommends new lung cancer drug

The National Institute for Health and Clinical Excellence (NICE) has issued final guidance recommending Tarceva (erlotinib) as a treatment for non-small cell lung cancer...

'Epigenetic' therapy shows promise for hard-to-treat lung cancer

A new 'epigenetic' therapy appears to be able to prolong the life of patients with late-stage non-small cell lung cancer (NSCLC), according to the results of a small...

Erlotinib improves progression-free survival in non-small cell lung cancer

The cancer drug erlotinib triples how long certain patients with non-small cell lung cancer (NSCLC) survive without their disease progressing, according to researchers at...

New genetic fault linked to lung cancer in non-smokers

Korean scientists have discovered a gene fault that may be behind thousands cases of lung cancer worldwide, particularly in non-smokers.

Pages